is semaglutide hard on the kidneys use tied to lower kidney disease risk in obesity Semaglutide: A Breakthrough for Chronic

The synergy between estrogen replacement and peptide therapy is not just additive

We have you covered

69 Conversely, GLP-1 receptors in the myenteric plexus activate nitrergic and cyclic AMP signaling pathways to inhibit vagal activity within the gut, 70 resulting in decreased phasic gastric contractions, delayed gastric emptying, reduced gastric acid secretion, and increased fasting and postprandial gastric volumes

Additionally, a streptozotocin (STZ)-induced type 1 diabetes rat model, which also results in reduced insulin through cell loss, was reported to have showed decreased endothelial ZO-1 and occludin and increased MMP activity in blood (Hawkins et al., 2007), suggesting changes in vascular permeability can be a direct consequence of high blood glucose